Topic: Institute News
-
Scripps Research’s Skaggs Graduate School awards doctoral degrees to 31st graduating class
Commencement ceremony will be livestreamed via Zoom and on institute’s Facebook page.
-
Leading minds on COVID-19 come together for pandemic preparedness symposium, hosted by Scripps Research
Symposium marks public launch of Center for Antiviral Medicines & Pandemic Preparedness (CAMPP) to develop new antiviral therapies in preparation for future pandemics.
-
Calibr and Bill & Melinda Gates Medical Research Institute announce licensing agreement for novel candidate tuberculosis treatment compound
Calibr transitions investigational compound CLB073 to Gates MRI to advance development.
-
Scripps Research announces inaugural winners of Collaborative Innovation Fund
The three winning teams receive grants to support highly innovative research focused on transforming catalysis, biological imaging, and our understanding of interorgan communication.
-
Scripps Research mourns loss of valued advisor and former board member Christopher Walsh
A noted biochemist, Walsh had an enormous impact on academic research, drug discovery and the biopharmaceutical field.
-
Calibr advances multiple clinical programs while securing significant funding for global health and other disease initiatives
2022 year-end roundup: Clinical success and consistent funding validate Calibr’s pioneering approach to drug discovery.
-
Thirteen Scripps Research scientists featured on global list of most highly cited researchers
Thirteen scientists were named to Clarivate’s Highly Cited Researchers list: a methodology for identifying the most influential researchers from around the world.
-
Scripps Research awarded NIH grant to enhance biosafety level 3 facility to address viruses of pandemic concern
The $3.8 million award will expand the institute’s research programs aimed at identifying therapeutics for various RNA viruses.
-
Raphael (Donghyun) Park joins Scripps Research Fellows Program to develop novel ways of addressing tuberculosis
Park’s expertise in high-resolution imaging will enable a detailed look at bacterial pathogenesis.
-
New Scripps Research Fellow Shannon Miller is advancing delivery methods for novel gene-editing technologies
Miller brings a wealth of experience in genome editing to accelerate potential therapeutics for genetic diseases.